A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT02917941 · COMPLETED
Trial details
- NCT number
- NCT02917941
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2019-08-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.